Zimmer Biomet Holdings, Inc. Stock Börse Stuttgart

Equities

ZIM

US98956P1021

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 02:09:30 2024-06-07 EDT 5-day change 1st Jan Change
104.1 EUR +0.07% Intraday chart for Zimmer Biomet Holdings, Inc. -1.89% -4.85%

Financials

Sales 2024 * 7.76B 7.13B 10.61B Sales 2025 * 8.12B 7.45B 11.1B Capitalization 23.32B 21.42B 31.88B
Net income 2024 * 986M 905M 1.35B Net income 2025 * 1.19B 1.09B 1.62B EV / Sales 2024 * 3.56 x
Net Debt 2024 * 4.34B 3.98B 5.93B Net Debt 2025 * 3.03B 2.79B 4.15B EV / Sales 2025 * 3.25 x
P/E ratio 2024 *
23.3 x
P/E ratio 2025 *
20 x
Employees -
Yield 2024 *
0.85%
Yield 2025 *
0.86%
Free-Float 64.77%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Zimmer Biomet Holdings, Inc.

1 week-1.89%
Current month-1.09%
1 month-6.47%
3 months-9.84%
6 months-3.25%
Current year-4.85%
More quotes
1 week
103.00
Extreme 103
105.85
1 month
103.00
Extreme 103
112.65
3 years
95.59
Extreme 95.59397088
136.88
5 years
71.04
Extreme 71.03898
146.00
10 years
69.18
Extreme 69.1772688
146.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 18-10-31
Director of Finance/CFO 55 19-06-30
Chief Tech/Sci/R&D Officer - 21-06-06
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 68 08-12-31
Director/Board Member 51 14-12-11
More insiders
Date Price Change
24-06-07 103.6 -0.38%
24-06-06 104 0.00%
24-06-05 104 +0.63%
24-06-04 103.4 -2.31%
24-06-03 105.8 +0.62%

Delayed Quote Börse Stuttgart, June 07, 2024 at 02:02 am

More quotes
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
113.4 USD
Average target price
136.4 USD
Spread / Average Target
+20.28%
Consensus